Journal Article10.1002/jcp.30941
Multifaceted functions of RPS27a: An unconventional ribosomal protein
32
TL;DR: The ribosomal protein S27a (RPS27a) is cleaved from the fusion protein ubiquitin by a deubiquitinating enzyme as discussed by the authors , which is involved in the development and poor prognosis of various cancers such as colorectal cancer, liver cancer, chronic myeloid leukemia, and renal carcinoma.
read more
Abstract: The ribosomal protein S27a (RPS27a) is cleaved from the fusion protein ubiquitin–RPS27a (Ub–RPS27a). Generally, Ub and RPS27a are coexpressed as a fusion protein but function independently after Ub is cleaved from RPS27a by a deubiquitinating enzyme. As an RP, RPS27a assembles into ribosomes, but it also functions independently of ribosomes. RPS27a is involved in the development and poor prognosis of various cancers, such as colorectal cancer, liver cancer, chronic myeloid leukemia, and renal carcinoma, and is associated with poor prognosis. Notably, the murine double minute 2/P53 axis is a major pathway through which RPS27a regulates cancer development. Moreover, RPS27a maintains sperm motility, regulates winged aphid indirect flight muscle degeneration, and facilitates plant growth. Additionally, RPS27a is a metalloprotein and mercury (Hg) biomarker. In the present review, we described the origin, structure, and biological functions of RPS27a.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance
Martin Schröder,Martin Renatus,Xiaoyou Liang,Fabian Meili,Thomas Zoller,Sandrine Ferrand,François Gauter,Xiaoyan Li,Frederic Sigoillot,Scott Gleim,Therese-Marie Stachyra,Jason R Thomas,Damien Begue,Maryam Khoshouei,Peggy Lefeuvre,Rita Andraos-Rey,BoYee Chung,Renate Ma,Benika J. Pinch,Andreas Hofmann,Markus Schirle,Niko Schmiedeberg,Patricia Imbach,Delphine Gorses,Keith Calkins,Beatrice Bauer-Probst,Magdalena Maschlej,Matt Niederst,Robert Maher,Martin Henault,John Alford,Erik Ahrne,Luca Tordella,Greg Hollingworth,Nicolas H. Thomä,Anna Vulpetti,Thomas Radimerski,Philipp Holzer,Seth Carbonneau,Claudio R. Thoma +39 more
TL;DR: Researchers developed DCAF1-based PROTACs that target clinically validated proteins, overcoming resistance to existing degraders by utilizing a novel E3 ligase receptor, DCAF1, and demonstrating efficacy in cells with acquired and intrinsic resistance.
32
Elevated temperatures reduce population-specific transcriptional plasticity in developing lake sturgeon (Acipenser fulvescens)
TL;DR: For example, the authors showed that lake sturgeon populations responded to elevated acclimation temperatures by downregulating the transcription of genes involved in protein synthesis and energy production, and there were population-specific thresholds for the downregulation of processes promoting transcriptional plasticity as well as mitochondrial function.
11
Effects of parental exposure to amitriptyline on the survival, development, behavior, and gene expression in zebrafish offspring
Anqi Liu,Chen Chen,Kun Chen,Yanhong Shi,Robert C. Grabowski,Xuchun Qiu +5 more
TL;DR: Results showed that parental exposure to AMI induced tachycardia and increased mortality in F1 zebrafish, and suggested that toxicity of parental exposure to the offspring of fish should receive greater attention.
6
Reinstating targeted protein degradation with DCAF1 PROTACs in CRBN PROTAC resistant settings
Martin Schröder,Martin Renatus,Xi-long Liang,Fabian Meili,Thomas Zoller,Sandrine Ferrand,François Gauter,Frederic Sigoillot,Scott Gleim,Jason R. Thomas,Damien Begue,Rita Andraos-Rey,BoYee Chung,Seth Carbonneau,Benika J. Pinch,Andreas Hofmann,Markus Schirle,Patricia Imbach,Delphine Gorses,Keith Calkins,Beatrice Bauer-Probst,Matthew J. Niederst,Rob Maher,Martin Henault,John Alford,Erik Ahrne,Gregory John Hollingworth,Nicolas H. Thomä,Anna Vulpetti,Thomas Radimerski,Philipp Holzer,Claudio R. Thoma +31 more
TL;DR: In this article , the essential E3 ligase receptor DCAF1 can be harnessed for targeted protein degradation (TPD) utilizing a potent, non-covalent DCAF 1 binder.
Journal Article
Ribosomal proteins are blood biomarkers and associated with CD4+ T cell activation in Alzheimer's disease: a study based on machine learning strategies and scRNA-Seq data validation.
01 Jan 2023
TL;DR: Wang et al. as discussed by the authors obtained four bulk and single-cell RNA-sequencing peripheral blood samples related to Alzheimer's disease from public databases, using Boruta and LASSO machine learning algorithms, and constructed a diagnostic model using lightGBM.
4
References
Breaking the chains: structure and function of the deubiquitinases.
TL;DR: DUBs are subject to multiple layers of regulation that modulate both their activity and their specificity, and due to their wide-ranging involvement in key regulatory processes, these enzymes might provide new therapeutic targets.
2.1K
The p53-mdm-2 autoregulatory feedback loop
TL;DR: The mdm-2 gene is shown here to contain a p53 DNA-binding site and a genetically responsive element such that expression of the mdm -2 gene can be regulated by the level of wild-type p53 protein.
Recognition and Processing of Ubiquitin-Protein Conjugates by the Proteasome
TL;DR: The proteasome contains deubiquitinating enzymes (DUBs) that can remove ubiquitin before substrate degradation initiates, thus allowing some substrates to dissociate from the proteasomes and escape degradation.
1.8K
Ubiquitin-dependent protein degradation
TL;DR: A growing number of cellular regulatory mechanisms are being linked to protein modification by the polypeptide ubiquitin, including key transitions in the cell cycle, class I antigen processing, signal transduction pathways, and receptor-mediated endocytosis.
1.8K
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.
TL;DR: Studies now aim to identify molecular markers and imaging techniques that can detect patients with HCC at earlier stages and better predict their survival time and response to treatment.
1.6K